Vincy Eklöf
YOU?
Author Swipe
View article: Data from The Role of the CpG Island Methylator Phenotype in Colorectal Cancer Prognosis Depends on Microsatellite Instability Screening Status
Data from The Role of the CpG Island Methylator Phenotype in Colorectal Cancer Prognosis Depends on Microsatellite Instability Screening Status Open
Purpose: The aim of this study was to relate the CpG island methylator phenotype (CIMP; characterized by extensive promoter hypermethylation) to cancer-specific survival in colorectal cancer, taking into consideration relevant clini…
View article: Supplementary Data from The Role of the CpG Island Methylator Phenotype in Colorectal Cancer Prognosis Depends on Microsatellite Instability Screening Status
Supplementary Data from The Role of the CpG Island Methylator Phenotype in Colorectal Cancer Prognosis Depends on Microsatellite Instability Screening Status Open
Supplementary Data from The Role of the CpG Island Methylator Phenotype in Colorectal Cancer Prognosis Depends on Microsatellite Instability Screening Status
View article: Supplementary Data from The Role of the CpG Island Methylator Phenotype in Colorectal Cancer Prognosis Depends on Microsatellite Instability Screening Status
Supplementary Data from The Role of the CpG Island Methylator Phenotype in Colorectal Cancer Prognosis Depends on Microsatellite Instability Screening Status Open
Supplementary Data from The Role of the CpG Island Methylator Phenotype in Colorectal Cancer Prognosis Depends on Microsatellite Instability Screening Status
View article: Data from The Role of the CpG Island Methylator Phenotype in Colorectal Cancer Prognosis Depends on Microsatellite Instability Screening Status
Data from The Role of the CpG Island Methylator Phenotype in Colorectal Cancer Prognosis Depends on Microsatellite Instability Screening Status Open
Purpose: The aim of this study was to relate the CpG island methylator phenotype (CIMP; characterized by extensive promoter hypermethylation) to cancer-specific survival in colorectal cancer, taking into consideration relevant clini…
View article: Parvimonas micra as a putative non-invasive faecal biomarker for colorectal cancer
Parvimonas micra as a putative non-invasive faecal biomarker for colorectal cancer Open
View article: Improved monitoring of inflammatory activity in patients with ulcerative colitis by combination of faecal tests for haemoglobin and calprotectin
Improved monitoring of inflammatory activity in patients with ulcerative colitis by combination of faecal tests for haemoglobin and calprotectin Open
Faecal calprotectin (FC) tests and faecal immunological tests (FIT) for haemoglobin have been used to monitor disease activity in patients with ulcerative colitis (UC) but used alone they have some limitation concerning the predictive abil…
View article: Proton pump inhibitor use is associated with elevated faecal calprotectin levels. A cross-sectional study on subjects referred for colonoscopy
Proton pump inhibitor use is associated with elevated faecal calprotectin levels. A cross-sectional study on subjects referred for colonoscopy Open
More than one-third of the patients with a normal colonoscopy performed in clinical routine had a slightly elevated FC level. Our results emphasise the need for attention to age, the use of proton pump inhibitors, non-steroid anti-inflamma…
View article: The Combined Value of Faecal Haemoglobin andCalprotectin in Diagnosis of Colorectal Cancer inSymptomatic Patients Referred to Colonoscopy
The Combined Value of Faecal Haemoglobin andCalprotectin in Diagnosis of Colorectal Cancer inSymptomatic Patients Referred to Colonoscopy Open
Aim: To investigate the diagnostic value of a combined analyses of faecal immunological haemoglobin (FIT) and faecal calprotectin (FC) in detection of colorectal cancer (CRC). Methods: Out-patients (n=1440) referred to the endoscopy unit w…
View article: Cancer‐associated fecal microbial markers in colorectal cancer detection
Cancer‐associated fecal microbial markers in colorectal cancer detection Open
Colorectal cancer (CRC) is the second most common cause of cancer death in the western world. An effective screening program leading to early detection of disease would severely reduce the mortality of CRC. Alterations in the gut microbiot…
View article: Patients with longstanding ulcerative colitis in remission do not have more irritable bowel syndrome-like symptoms than controls
Patients with longstanding ulcerative colitis in remission do not have more irritable bowel syndrome-like symptoms than controls Open
View article: SOX2 expression is associated with a cancer stem cell state and down-regulation of CDX2 in colorectal cancer
SOX2 expression is associated with a cancer stem cell state and down-regulation of CDX2 in colorectal cancer Open
View article: Additional file 1: of Patients with longstanding ulcerative colitis in remission do not have more irritable bowel syndrome-like symptoms than controls
Additional file 1: of Patients with longstanding ulcerative colitis in remission do not have more irritable bowel syndrome-like symptoms than controls Open
The identities of all subjects are protected in the supporting data set and the file contain data on all parameters included in the manuscript. (XLS 53 kb)
View article: The infiltration, and prognostic importance, of Th1 lymphocytes vary in molecular subgroups of colorectal cancer
The infiltration, and prognostic importance, of Th1 lymphocytes vary in molecular subgroups of colorectal cancer Open
Giving strong prognostic information, T‐cell infiltration is on the verge of becoming an additional component in the routine clinical setting for classification of colorectal cancer (CRC). With a view to further improving the tools for pro…